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AbstrACt
Introduction Universal health coverage (UHC) includes 
the dimensions of equity in access, quality services that 
improve health and protection against financial hardship. 
Cataract continues to be the leading cause of blindness 
globally, despite cataract surgery being an efficacious 
intervention. The aim of this scoping review is to map the 
nature, extent and global distribution of data on cataract 
services for UHC in terms of equity, access, quality and 
financial protection.
Methods and analysis The search will be constructed 
by an Information Specialist and undertaken in MEDLINE, 
Embase and Global Health databases. We will include all 
published non- interventional primary research studies and 
systematic reviews that report a quantitative assessment 
of access, equity, quality or financial protection of cataract 
surgical services for adults at the subnational, national, 
regional or global level from population- based surveys or 
routinely collected health service data since 1 January 
2000 and published through to February 2020.
Screening and data charting will be undertaken using 
Covidence systematic review software. Titles and abstracts 
of identified studies will be screened by two authors 
independently. Full- text articles of potentially relevant 
studies will be obtained and reviewed independently 
by two authors against the inclusion criteria. Any 
discrepancies between the authors will be resolved 
by discussion, and with a third author as necessary. 
A data charting form will be developed and piloted on 
three studies by three authors and amendments made 
as necessary. Data will be extracted by two reviewers 
independently and summarised narratively and using 
maps.
Ethics and dissemination Ethical approval was not 
sought as the scoping review will only use published and 
publicly accessible data. The review will be published in 
an open access peer- reviewed journal. A summary of the 
results will be developed for website posting, stakeholder 
meetings and inclusion in the ongoing Lancet Global 
Health Commission on Global Eye Health.
IntroduCtIon
Eye health and vision impairment represent 
a major global health concern. In the recent 
World Report on Vision, WHO outlined how the 
provision of quality eye care services contrib-
utes directly to achieving universal health 
coverage (UHC).1 WHO estimated that in 
2020 up to 2.2 billion people have some form 
of vision impairment and that this figure 
is projected to rise leading to an increased 
burden on health systems.1
Monitoring progress towards uHC
The WHO defines UHC in the following 
terms:
Universal health coverage (UHC) means 
that all people and communities can use 
the promotive, preventive, curative, re-
habilitative and palliative health services 
they need, of sufficient quality to be ef-
fective, while also ensuring that the use of 
these services does not expose the user to 
financial hardship.2
It has three broad principles: (1) equity 
in access; (2) quality services that improve 
health; (3) protection against financial risk. 
WHO and the World Bank have developed 
a framework for tracking progress towards 
UHC.3 This focuses on two elements:
1. Measuring the coverage of essential health 
services, as a proportion of the population 
that can access essential quality health 
services.
strengths and limitations of this study
 ► The broad scope of this review will result in the first 
synthesis to date of data on the universal health cov-
erage dimensions of cataract surgical services.
 ► Another strength is that we will include studies from 
all world regions and high- income, low- income and 
middle- income countries with no language restric-
tions, to give a global picture of cataract services.
 ► A potential limitation is the paucity of available infor-
mation on the ‘financial protection’ dimension.
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2. Measuring financial protection by determining the 
proportion of the population in whom direct payment 
made to obtain health services leads to financial hard-
ship and/or a threat to living standards.3
A variety of different types of indicators are used. Effec-
tive service coverage indicators measure the proportion 
of people in need of services who receive services of 
sufficient quality to obtain potential health gains; these 
are preferred if available. Service coverage indicators 
measure the proportion of the population that needs a 
service that receive it. Proxy indicators are sometimes 
used where service coverage indicators are not available, 
but provide a correlated indication of the provision of a 
health service.3 4
The WHO and World Bank have selected a panel of 
16 ‘tracer indicators’ to monitor progress towards UHC.2 
There is currently no eye health related indicator among 
this panel, though effective cataract surgical coverage 
(eCSC) and effective refractive error coverage were 
proposed in WHO’s Thirteenth General Programme 
of Work 2019–2023 Impact Framework.5 In addition to 
measuring population- level coverage, it is important to 
measure equity in service provision, by disaggregating the 
data and comparing subpopulations such as wealth quin-
tiles, education, sex, age and geographical region.3
Monitoring cataract services for uHC
Cataract is the leading cause of blindness globally and is 
the second leading cause of vision impairment.6 The last 
three decades have seen a marked increase in available 
data on vision impairment due to cataract, as well as cata-
ract services. These data have enabled calculation of indi-
cators of access and quality of cataract surgery, including:
 ► Cataract surgical rate (CSR): the number of cataract 
operations per million population per year.7
 ► CSC: the number of people in a population who have 
received cataract surgery as a proportion of those 
having operable and operated cataract.6
 ► Cataract surgical outcome: the presenting and/or 
best- corrected visual acuity of the operated eye.
 ► ECSC: the number of people in a population with 
operated cataract and a visual acuity of 6/18 or better 
as a proportion of those having operable and oper-
ated cataract.8
eCSC, has the characteristics of an effective service 
coverage indicator, as preferred by the WHO/World 
Bank, as it combines information on the proportion of 
the population covered and the outcome of the surgical 
intervention.9 10
Disaggregation of larger datasets has allowed analyses 
of equity in cataract surgery as well, for example, to high-
light existing gender disparities in CSC.11–15 Much less 
data are available quantifying financial aspects of cataract 
services. To our knowledge, no existing synthesis of the 
distribution and quantity of known evidence for the UHC 
dimensions of cataract surgery has been undertaken. The 
aim of this scoping review is to map the nature, extent and 
global distribution of data on cataract surgical services 
for UHC in terms of equity, access, quality and financial 
protection.
We chose to undertake a scoping review rather than 
an alternative evidence synthesis approach because we 
wished to identify and map the available evidence, which 
we anticipate will be heterogeneous.16
MEtHods
objectives/scoping review questions
We aim to answer the following two questions in relation 
to cataract services for UHC:
1. What is the nature, extent and global distribution 
of data on the coverage and effectiveness of cataract 
services?
2. What is the nature, extent and global distribution of 
data on financial protection in relation to cataract 
services?
Protocol and registration
The protocol for this scoping review is reported according 
to the relevant sections of the Preferred Reporting Items 
for Systematic Reviews and Meta- Analyses Extension for 
Scoping Reviews (PRISMA) guideline (online supple-
mentary annex 1).17 The protocol is registered on the 
Open Science Framework (https:// osf. io/ k3mwg/).
Eligibility criteria
We will include all published prospective and retrospec-
tive primary research studies and systematic reviews that 
report a quantitative assessment of access, equity, quality 
or financial protection of cataract surgical services for 
adults at the subnational, national, regional or global 
level (examples outlined in table 1). We will include 
population- level observational studies and reports, 
including those that use routinely collected data (such 
as in health information systems) and household surveys 
such as Rapid Assessment of Avoidable Blindness (RAAB) 
surveys. We will exclude intervention studies and studies 
within clinical subpopulations as their outcomes can 
be different to the general population (eg, people with 
diabetes, people with age- related macular degeneration). 
We will exclude studies focused exclusively on cataract 
services for children (aged under 18 years), as these 
services differ substantially from those for age- related 
cataract.
To assess access we will include studies that report CSC 
and CSR, which are priority indicators for monitoring 
global eye health.18 Beyond these, we will include studies 
that report the number and distribution of human 
resources and surgical facilities. We acknowledge that 
there are many quantitative and qualitative elements of 
healthcare quality as defined by WHO.19 However, for 
the purposes of this review, we will focus on only three—
eCSC, vision outcomes of cataract surgery and reported 
complications. We anticipate the literature reporting 
financial protection associated with cataract surgery will 
be limited. We will include studies and surveys that report 
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Table 1 Primary and secondary outcomes included in the review, mapped against UHC dimensions
UHC dimension Primary cataract indicator Secondary cataract indicator
Access (Coverage)—the availability of 
good health services within reasonable 
reach and available at the point of need.
Cataract surgical coverage  ► Cataract surgical rate23
 ► No of operating surgeons by country
 ► No and distribution of operating 
centres by country
Quality—limited to the WHO quality 
elements of effectiveness and safety
Effective cataract surgical coverage8  ► Cataract surgical outcome11
 ► Complication rates per surgeon/
institution
Financial Protection—direct payments 
made to obtain health services do not 
expose people to financial hardship and 
do not threaten living standards
Rate of Catastrophic Spending on 
cataract surgery (25% of total household 
expenditure per WHO)
Cost of cataract Surgery (to patient/
household)24 25
Rate of Impoverishing Spending on 
cataract surgery (relative to national or 
international poverty line)
Equity—services are accessible to all 
who need them
Disaggregation of any of the primary or 
secondary indicators by sex/gender13 15 26
Disaggregation of any of the primary 
or secondary indicators by any other 
PROGRESS factor20:
  Place of residence (eg, urban/rural, 
subnational unit)
  Race/ethnicity/culture/language
  Occupation
  (Gender/sex)
  Religion
  Education
  Socioeconomic status12
  Social capital (eg, marital status)27
‘catastrophic’ and ‘impoverishing’ spending on cataract 
surgery according to WHO definitions, as well as other 
related measures of personal and government expendi-
ture on cataract surgery and service provision (table 1). 
We will use the PROGRESS acronym20 to assess equity: 
Place of residence; Race/ethnicity/culture/language; 
Occupation; Gender/sex; Religion; Education; Socioeco-
nomic status; Social capital/ networks.
Studies will be limited to those including data collected 
since 1 January 2000 to provide a contemporary view of 
cataract services. The search strategy will be undertaken 
without language restrictions and translation will be 
arranged when required.
search strategy
We will search Embase, MEDLINE and Global Health 
databases for studies published from 1 January 2000 to 
February 2020 using search strategies developed by an 
Information Specialist from Cochrane Eyes and Vision 
(IG) (MEDLINE Search Strategy included in online 
supplementary annex 2). We will provide a list of included 
studies and reports to field experts and request they iden-
tify additional sources of both published and unpublished 
reports for consideration in the review.
We will use the RAAB repository (http:// raabdata. 
info/) to identify all reports and data from sub- national 
and national RAAB studies taken from 1 January 2000 
onwards.
To identify government and non- government reports 
in the grey literature, we will use a checklist adapted 
from the Canadian Agency for Drugs and Technologies 
in Health Grey Matters checklist to undertake a search of 
relevant websites.21
The following grey literature databases and repositories 
will be searched:
 ► OpenGrey (http://www. opengrey. eu/).
 ► Global Burden of Disease (http://www. healthdata. 
org/ gbd).
 ► Global Health Data Exchange (http:// ghdx. health-
data. org/).
 ► WHO (https://www. who. int/ library/ en/).
 ► International Agency for the Prevention of Blindness 
(https://www. iapb. org/ global- vision- database- 
maps/).
 ► National Ministry of Health websites.
selection of sources of evidence
All titles and abstracts will be screened by at least two 
investigators independently using Covidence systematic 
review software (Veritas Health Innovation, Melbourne, 
Australia; available at www. covidence. org). Assessment 
of eligibility for inclusion will be carried out by two 
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investigators independently with a third investigator 
reviewing discrepancies. Reference lists of all included 
articles will be examined to identify further potentially 
relevant reports. The study selection process will be 
summarised in a PRISMA flow diagram.
data charting
The data charting form will be developed in Covidence 
and piloted by investigators prior to use. Data charting 
will be carried out by two investigators independently. 
As data sources are expected to be heterogeneous and 
broad in nature, data charting will be an iterative process 
throughout the review. Information that is absent or 
unclear will be addressed by contacting study authors 
with up to three attempts by email. The result of these 
attempts will be reported.
Because our focus is on mapping the availability of 
evidence, we did not to undertake quality appraisal of 
individual studies.17
data items
Source characteristics
 ► Published Data Characteristics—Author(s), Year of 
Publication, Journal, Language.
 ► Grey Literature Characteristics—Author (Organ-
isation, eg, WHO, Ministry of Health), Year of 
Publication, Source Website (eg, government/non- 
government organisation), Language, Type of Liter-
ature (Report, Thesis, Technical Report, Statistics, 
other).
Study characteristics
Type of study, countries/regions investigated, level of 
analysis (subnational, national, regional, global), sample 
details (frame, size), year of data collection, outcome(s) 
reported (as outlined in table 1), UHC dimension(s) inves-
tigated (Access, Equity, Quality, Financial Protection).
synthesis of results
Following data charting, we will undertake narrative 
synthesis. Where possible maps will be used to summarise 
the available global, regional, national and subnational 
distribution and proportion of studies reporting each UHC 
dimension for cataract surgery. Tables will be constructed 
to demonstrate distribution of studies by region and (if 
appropriate) country. Where enough data are identified, 
further quantitative analyses of primary or secondary 
outcomes may be undertaken as a subsequent analysis.
Patient and public involvement
This protocol was developed with input from the Commis-
sioners of the Lancet Global Health Commission on Global 
Eye Health,22 which includes people with lived experi-
ence of vision impairment (and cataract surgery), policy- 
makers, academics, clinicians, government eye health 
programme leaders and advocacy specialists.
EtHICs And dIssEMInAtIon
As this scoping review will only consider publicly available 
literature and reports, no ethics approval was sought. 
Findings will be published in an open- access peer- 
reviewed journal, and a summary will be developed for 
website access and stakeholder meetings. A summary of 
the findings will also be included in the ongoing Lancet 
Global Health Commission on Global Eye Health.22
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